Synopsis
0
CEP/COS
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Click Us!
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
JDMF
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36114
Submission : 2021-07-31
Status :
Type : II
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39226
Submission : 2024-01-08
Status :
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Market Place
APIs
Reply
12 Jul 2023
Reply
10 Jun 2022
Reply
09 Oct 2021
Reply
23 May 2019
Reply
14 Jul 2018
Reply
07 May 2018
Reply
07 Jun 2017
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Loxoprofen Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Loxoprofen Sodium, including repackagers and relabelers. The FDA regulates Loxoprofen Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Loxoprofen Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Loxoprofen Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Loxoprofen Sodium supplier is an individual or a company that provides Loxoprofen Sodium active pharmaceutical ingredient (API) or Loxoprofen Sodium finished formulations upon request. The Loxoprofen Sodium suppliers may include Loxoprofen Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Loxoprofen Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Loxoprofen Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Loxoprofen Sodium active pharmaceutical ingredient (API) in detail. Different forms of Loxoprofen Sodium DMFs exist exist since differing nations have different regulations, such as Loxoprofen Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Loxoprofen Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Loxoprofen Sodium USDMF includes data on Loxoprofen Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Loxoprofen Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Loxoprofen Sodium suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Loxoprofen Sodium Drug Master File in Japan (Loxoprofen Sodium JDMF) empowers Loxoprofen Sodium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Loxoprofen Sodium JDMF during the approval evaluation for pharmaceutical products. At the time of Loxoprofen Sodium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Loxoprofen Sodium suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Loxoprofen Sodium Drug Master File in Korea (Loxoprofen Sodium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Loxoprofen Sodium. The MFDS reviews the Loxoprofen Sodium KDMF as part of the drug registration process and uses the information provided in the Loxoprofen Sodium KDMF to evaluate the safety and efficacy of the drug.
After submitting a Loxoprofen Sodium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Loxoprofen Sodium API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Loxoprofen Sodium suppliers with KDMF on PharmaCompass.
A Loxoprofen Sodium written confirmation (Loxoprofen Sodium WC) is an official document issued by a regulatory agency to a Loxoprofen Sodium manufacturer, verifying that the manufacturing facility of a Loxoprofen Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Loxoprofen Sodium APIs or Loxoprofen Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Loxoprofen Sodium WC (written confirmation) as part of the regulatory process.
click here to find a list of Loxoprofen Sodium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Loxoprofen Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Loxoprofen Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Loxoprofen Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Loxoprofen Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Loxoprofen Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Loxoprofen Sodium suppliers with NDC on PharmaCompass.
Loxoprofen Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Loxoprofen Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Loxoprofen Sodium GMP manufacturer or Loxoprofen Sodium GMP API supplier for your needs.
A Loxoprofen Sodium CoA (Certificate of Analysis) is a formal document that attests to Loxoprofen Sodium's compliance with Loxoprofen Sodium specifications and serves as a tool for batch-level quality control.
Loxoprofen Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Loxoprofen Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Loxoprofen Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Loxoprofen Sodium EP), Loxoprofen Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Loxoprofen Sodium USP).
LOOKING FOR A SUPPLIER?
Comment (5)
